CNS Delivery of RNA Therapeutics Using LAT1 Target Polymeric Nanoparticle
Time: 10:30 am
day: Conference Day One
Details:
- Biorchestra Drug Delivery System (BDDSTM) is a proprietary technology utilizing non-lipid polymer ion complex and LAT1 targeting ligand for BBB penetration
- Preclinical assessment on ALS and Epilepsy of ASO therapeutics with BDDSTM technology
- BDDSTM technology is compatible with multiple RNA species with various lengths (e.g., ASO, siRNA & mRNA) and shows a therapeutic potency in preclinical evaluation
